Evidence map›Paper›PMID 27193223›Full record

ArticleJournal of human genetics2016

Androgen receptor CAG polymorphism and sporadic and early-onset prostate cancer among Mexican men.

Rocío Gómez, Luisa Torres-Sánchez, Rafael Camacho-Mejorado, Ana I Burguete-García, Ruth Argelia Vázquez-Salas, Gabriela A Martínez-Nava, Carla Santana, Gino Noris

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Cancers · 2024
    Article
  6. Article
  7. Article
  8. Contribution ofOncotarget · 2019
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rocío GómezDepartamento de Toxicología. Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico DF, México.
Luisa Torres-SánchezInstituto Nacional de Salud Pública, Centro de Investigación en Salud Poblacional, Cuernavaca, México.
Rafael Camacho-MejoradoDepartamento de Toxicología. Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico DF, México.
Ana I Burguete-GarcíaInstituto Nacional de Salud Pública, Centro de Investigación en Enfermedades Infecciosas, Cuernavaca, México.
Ruth Argelia Vázquez-SalasInstituto Nacional de Salud Pública, Centro de Investigación en Salud Poblacional, Cuernavaca, México.
Gabriela A Martínez-NavaInstituto Nacional de Salud Pública, Centro de Investigación en Enfermedades Infecciosas, Cuernavaca, México.
Carla SantanaLaboratorio BIMODI (Biología Molecular Diagnóstica), Santiago de Querétaro, México.
Gino NorisLaboratorio BIMODI (Biología Molecular Diagnóstica), Santiago de Querétaro, México.
Instituto Nacional de Salud Pública · MXInstituto Mexicano de Oftalmología IAP · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A short CAG repeat length in the gene encoding for the androgen receptor (AR) has been associated with prostate cancer (PC) risk and aggressiveness. In Latino men, information on this association is scarce. Hence, the aim of this study was to evaluate this association in Mexican males. Using fragment analysis by capillary electrophoresis, we determined the number of CAG repeats-(CAG)n-in AR gene from 158 incident PC cases and 326 age-matched healthy controls (±5 years), residing in Mexico City, Mexico. According to Gleason scale and age at diagnosis, cases were classified as high (⩾7) and low grade (<7), as well as early onset (<60 years) or late onset PC (⩾60 years). At diagnosis, 78% of cases were classified as high-grade and 26.6% as early onset. Men with sporadic (no family history of PC) and early-onset PC presented shorter CAG repeat length than controls (18.6±2.2 vs 19.5±2.5; P=0.02). Lower number of CAG repeats (CAG)⩽19 were associated with a greater risk for early-onset PC (odds ratio: 2.31; 95% confidence interval: 1.14-4.69). CAG repeat length could increase the risk for sporadic and early-onset PC. The best cutoff point for identifying at-risk subjects was (CAG)19. However, further studies are necessary to replicate our findings in subjects with a family history of PC and also to evaluate the association between CAG repeats length and disease progression.

Indexed as

Polymorphism, GeneticTrinucleotide RepeatsAdultAgedAged, 80 and overAge of OnsetAllelesCase-Control StudiesGene FrequencyGenotypeHumansMaleMexicoMiddle AgedNeoplasm GradingOdds RatioReceptors, Androgen

Identifiers

PMID27193223
OpenAlexW2406713030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.